Depression of Late Age-Related Macular Degeneration Patients in Korea

Asia-Pacific Journal of Ophthalmology

Volumn 2, Issue 1, 2013, Pages 23-27

  Lee, Won June ^a   Cho, Hee Yoon ^a   Kim, Dae Ho ^a   Yu, Hyeong Gon ^b   Oh, Jaeryung ^c   Kim, Jae Suk ^d   Moon, Sang Woong ^e  

^a Hanyang University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d Inje University College of Medicine   (South Korea)

^e Kyung Hee University Hospital   (South Korea)

Author keywords

age related macular degeneration; depression; ranibizumab

Indexed keywords

EID: 84989333272     PISSN: None     EISSN: 21620989     Source Type: Journal    
DOI: 10.1097/APO.0b013e31827be8b1     Document Type: Article

References (26)

1. Klein, R, Klein, BE, Jensen, SC, et al. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104 (1997), 7–21.
2. Pascolini, D, Mariotti, SP, Pokharel, GP, et al. 2002 Global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol 11 (2004), 67–115.
3. Kawasaki, R, Yasuda, M, Song, SJ, et al. The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology 117 (2010), 921–927.
4. Song, SJ, Youm, DJ, Chang, Y, et al. Age-related macular degeneration in a screened South Korean population: prevalence, risk factors, and subtypes. Ophthalmic Epidemiol 16 (2009), 304–310.
5. Crewe, JM, Morlet, N, Morgan, WH, et al. Quality of life of the most severely vision-impaired. Clin Exp Ophthalmol 39 (2011), 336–343.
6. Evans, JR, Fletcher, AE, Wormald, RP, Depression and anxiety in visually impaired older people. Ophthalmology 114 (2007), 283–288.
7. Hayman, KJ, Kerse, NM, La Grow, SJ, et al. Depression in older people: visual impairment and subjective ratings of health. Optom Vis Sci 84 (2007), 1024–1030.
8. Banerjee, A, Kumar, S, Kulhara, P, et al. Prevalence of depression and its effect on disability in patients with age-related macular degeneration. Indian J Ophthalmol 56 (2008), 469–474.
9. Brody, BL, Gamst, AC, Williams, RA, et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology 108 (2001), 1893–1900.
10. Casten, R, Rovner, BW, Leiby, BE, et al. Depression despite anti-vascular endothelial growth factor treatment of age-related macular degeneration. Arch Ophthalmol 128 (2010), 506–508.
11. Casten, RJ, Rovner, BW, Tasman, W, Age-related macular degeneration and depression: a review of recent research. Curr Opin Ophthalmol 15 (2004), 181–183.
12. Covinsky, KE, Yaffe, K, Lindquist, K, et al. Depressive symptoms in middle age and the development of later-life functional limitations: the long-term effect of depressive symptoms. J Am Geriatr Soc 58 (2010), 551–556.
13. Hart, PM, Chakravarthy, U, Stevenson, MR, et al. A vision specific functional index for use in patients with age related macular degeneration. Br J Ophthalmol 83 (1999), 1115–1120.
14. Rovner, BW, Casten, RJ, Leiby, BE, Variability in depressive symptoms predicts cognitive decline in age-related macular degeneration. Am J Geriatr Psychiatry 17 (2009), 574–581.
15. Rovner, BW, Casten, RJ, Tasman, WS, Effect of depression on vision function in age-related macular degeneration. Arch Ophthalmol 120 (2002), 1041–1044.
16. Slakter, JS, Stur, M, Quality of life in patients with age-related macular degeneration: impact of the condition and benefits of treatment. Surv Ophthalmol 50 (2005), 263–273.
17. Tasman, W, Rovner, B, Age-related macular degeneration: treating the whole patient. Arch Ophthalmol 122 (2004), 648–649.
18. Boyer, DS, Antoszyk, AN, Awh, CC, et al. Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 114 (2007), 246–252.
19. Joeres, S, Kaplowitz, K, Brubaker, JW, et al. Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration. Ophthalmology 115 (2008), 347–354.
20. Kaiser, PK, Blodi, BA, Shapiro, H, et al. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 114 (2007), 1868–1875.
21. Bae, JN, Cho, MJ, Development of the Korean version of the Geriatric Depression Scale and its short form among elderly psychiatric patients. J Psychosom Res 57 (2004), 297–305.
22. Kim, JY, Park, JH, Lee, JJ, et al. Standardization of the Korean version of the Geriatric Depression Scale: reliability, validity, and factor structure. Psychiatry Investig 5 (2008), 232–238.
23. Lee, Y, Shinkai, S, Correlates of cognitive impairment and depressive symptoms among older adults in Korea and Japan. Int J Geriatr Psychiatry 20 (2005), 576–586.
24. Maruko, I, Iida, T, Saito, M, et al. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 144 (2007), 15–22.
25. Cho, MJ, Lee, JY, Kim, BS, et al. Prevalence of the major mental disorders among the Korean elderly. J Korean Med Sci 26 (2011), 1–10.
26. Kim, JM, Stewart, R, Shin, IS, et al. Lifetime urbanrural residence, social support and late-life depression in Korea. Int J Geriatr Psychiatry 19 (2004), 843–851.